Evidence map›Paper›PMID 33174016›Full record

ArticleMolecular medicine reports2020

Anti‑inflammatory effects of leaf and branch extracts of honeyberry (Lonicera caerulea) on lipopolysaccharide‑stimulated RAW264.7 cells through ATF3 and Nrf2/HO‑1 activation.

Mi-Yun An, Hyun Ji Eo, Ho Jun Son, Na Gyeong Geum, Gwang Hun Park, Jin Boo Jeong

Open access · bronzeAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Systematic Review of Cardio-Metabolic Properties ofAntioxidants (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Honeysuckle Berry (Molecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Comparative Evaluation ofFrontiers in pharmacology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mi-Yun AnDepartment of Medicinal Plant Resources, Andong National University, Andong, Gyeongsangbuk 36729, Republic of Korea.
Hyun Ji EoForest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju, Gyeongsangbuk 36040, Republic of Korea.
Ho Jun SonForest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju, Gyeongsangbuk 36040, Republic of Korea.
Na Gyeong GeumDepartment of Medicinal Plant Resources, Andong National University, Andong, Gyeongsangbuk 36729, Republic of Korea.
Gwang Hun ParkForest Medicinal Resources Research Center, National Institute of Forest Science, Yeongju, Gyeongsangbuk 36040, Republic of Korea.
Jin Boo JeongDepartment of Medicinal Plant Resources, Andong National University, Andong, Gyeongsangbuk 36729, Republic of Korea.
Andong National University · KRKorea Forest Service · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honeyberry (Lonicera caerulea) has long been used as a traditional medicine in China, Japan and northern Russia. Functional studies of honeyberry have mainly focused on the fruits, which have been reported to exert various pharmacological activities, including anti‑inflammatory activity, with limited or no studies on the other parts of the plant, such as the leaves and branches. In the present study, the anti‑inflammatory effects of extracts of the leaves (HBL), branches (HBB) and fruit (HBF) of honeyberry plant were evaluated in lipopolysaccharide (LPS)‑stimulated RAW264.7 cells. HBL and HBB significantly inhibited the production of pro-inflammatory mediators in LPS‑stimulated RAW264.7 cells, and the inhibitory effects of HBL and HBB were stronger than those of HBF. HBL and HBB blocked the nuclear accumulation of p65 independently of IκB‑α. HBL did not inhibit the phosphorylation of ERK1/2 or p38; however, HBB effectively inhibited the phosphorylation of p38 but not ERK1/2. HBL and HBB increased the expression of heme oxygenase‑1 (HO‑1) protein by inducing the nuclear accumulation of nuclear factor erythroid 2‑related factor 2 (Nrf2) through the activation of the reactive oxygen species (ROS)/p38 pathway; the reduction in inducible nitric oxide synthase (iNOS) and interleukin‑1β (IL‑1β) expression by HBL and HBB was inhibited by HO‑1 knockdown. In addition, HBL and HBB increased the expression of activating transcription factor‑3 (ATF3), and the reduction in iNOS and IL‑1β expression by HBL and HBB was inhibited by ATF3 knockdown. Collectively, HBL and HBB inhibited LPS‑induced nuclear factor‑κB activation by blocking the nuclear accumulation of p65, increasing HO‑1 expression through activation of the ROS/p38/Nrf2 pathway, and increasing ATF3 expression. Furthermore, HBB inhibited LPS‑induced p38 phosphorylation. These findings suggest that HBL and HBB may have great potential as natural products for the development of anti‑inflammatory drugs.

Indexed as

Activating Transcription Factor 3AnimalsAnti-Inflammatory AgentsChinaFruitHeme Oxygenase-1Inflammation MediatorsLipopolysaccharidesLoniceraMedicine, Chinese TraditionalMiceNF-E2-Related Factor 2NF-kappa BNF-KappaB Inhibitor alphaNitric Oxide Synthase Type IIPlant ExtractsActivating Transcription Factor 3Anti-Inflammatory AgentsHeme Oxygenase-1Inflammation MediatorsLipopolysaccharidesNF-E2-Related Factor 2NF-kappa BNF-KappaB Inhibitor alphaNitric Oxide Synthase Type IIPlant ExtractsReactive Oxygen Species

Identifiers

PMID33174016
PMCPMC7646977
OpenAlexW3096612817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.